Bausch Health Companies Inc. | Mid-cap | Healthcare
$6.79
1.95%
| Bausch Health Stock Comparison:
Bausch Health vs ZoetisBausch Health vs Haleon Plc - ADRBausch Health vs SupernusBausch Health vs Indivior PLCBausch Health vs Ani PharmaceuticalsBausch Health vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 9.6B
Gross Profit 6.8B 71.10%
Operating Income 1.9B 19.26%
Net Income -72.0M -0.75%
EPS (Diluted) -$0.13

Balance Sheet Metrics

Total Assets 26.5B
Total Liabilities 26.8B
Shareholders Equity -322.0M

Cash Flow Metrics

Operating Cash Flow 1.4B
Free Cash Flow 1.3B

Revenue & Profitability Trend

Bausch Health Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 9.6B 8.8B 8.1B 8.4B 8.0B
Cost of Goods Sold 2.8B 2.6B 2.4B 2.4B 2.2B
Gross Profit 6.8B 6.2B 5.8B 6.0B 5.8B
Research & Development 616.0M 604.0M 530.0M 473.0M 484.0M
Selling, General & Administrative 3.3B 2.9B 2.6B 2.6B 2.4B
Other Operating Expenses 1.1B 1.1B 1.2B 1.4B 1.6B
Total Operating Expenses 5.0B 4.6B 4.4B 4.5B 4.5B
Operating Income 1.9B 1.6B 1.4B 1.6B 1.3B
Pre-tax Income 167.0M -390.0M -129.0M -1.0B -934.0M
Income Tax 239.0M 221.0M 83.0M -87.0M -375.0M
Net Income -72.0M -611.0M -212.0M -937.0M -559.0M
EPS (Diluted) -$0.13 -$1.62 -$0.62 -$2.64 -$1.58

Income Statement Trend

Bausch Health Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 5.8B 5.6B 4.2B 5.6B 5.3B
Non-Current Assets 20.7B 21.8B 21.4B 23.6B 25.9B
Total Assets 26.5B 27.4B 25.7B 29.2B 31.2B
Liabilities
Current Liabilities 6.8B 4.3B 3.9B 5.2B 4.9B
Non-Current Liabilities 20.1B 23.1B 21.5B 24.0B 25.7B
Total Liabilities 26.8B 27.4B 25.4B 29.2B 30.6B
Equity
Total Shareholders Equity -322.0M -82.0M 260.0M -34.0M 605.0M

Balance Sheet Composition

Bausch Health Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -72.0M -611.0M -212.0M -937.0M -559.0M
Operating Cash Flow 1.4B 628.0M -669.0M 662.0M 900.0M
Investing Activities
Capital Expenditures -337.0M -215.0M -218.0M -269.0M -302.0M
Investing Cash Flow -464.0M -2.1B -253.0M 396.0M -277.0M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -868.0M 1.5B -474.0M -1.5B -2.3B
Free Cash Flow 1.3B 760.0M -996.0M 1.1B 802.0M

Cash Flow Trend

Bausch Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -47.00
Forward P/E 1.38
Price to Book -9.23
Price to Sales 0.23
PEG Ratio 1.38

Profitability Ratios

Profit Margin -0.41%
Operating Margin 11.91%
Return on Equity 14.29%
Return on Assets 4.31%

Financial Health

Current Ratio 1.35
Debt to Equity -89.63
Beta 0.28

Per Share Data

EPS (TTM) -$0.12
Book Value per Share -$3.20
Revenue per Share $26.39

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
bhc 2.3B -47.00 -9.23 14.29% -0.41% -89.63
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Supernus 1.8B 28.53 1.72 6.32% 9.27% 3.13
Indivior PLC 1.7B 530.50 -6.04 -0.57% -5.30% -1.29
Ani Pharmaceuticals 1.4B 51.63 3.16 -4.57% -3.12% 142.03

Financial data is updated regularly. All figures are in the company's reporting currency.